🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Hormonal treatment of perimenopausal women has frequently utilized oral con...
Status
Completed
Location
University of Colorado
Start Date
2012-04
Trial ID
NCT01613131
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of a topi...
Status
Completed
Location
Multiple Locations
Start Date
2003-09
Trial ID
NCT00391417
Treatments Being Tested
This is a new application from the Menopause Strategies: Finding Lasting An...
Status
Completed
Location
University of Minnesota
Start Date
2016-04
Trial ID
NCT02516202
Treatments Being Tested
The purpose of this research study is to understand the effects of testoste...
Status
Completed
Location
University of Washington
Start Date
2013-06
Trial ID
NCT01686828
The objective of this clinical trial is to explore the efficacy of menopaus...
Status
Unknown
Location
Beijing Tiantan Hospital
Start Date
2023-08-18
Trial ID
NCT05982470
Treatments Being Tested
To compare the use of Estrace ® vaginal cream against a placebo vaginal cre...
Status
Withdrawn
Location
Division of Urogynecology North Shore-LIJ School of Medicine
Start Date
2015-04
Trial ID
NCT02316249
Women living with HIV have been shown to experience more frequent and sever...
Status
Recruiting
Location
31788 Alabama CRS
Start Date
2026-04-09
Trial ID
NCT06856174
A Phase 2, Dose-ranging, 12-week Randomized, Double-blind, Placebo controll...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U
Start Date
2016-10
Trial ID
NCT02967510
The original purpose of this research study was to understand the effects o...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT00729859
Treatments Being Tested
This study is intended to establish the lowest effective dose of EstroGel® ...
Status
Completed
Location
Site 112
Start Date
2004-12-02
Trial ID
NCT00160173